← Organizations
Sponsor / Institution
University of California, Irvine
Organization-level profile for a sponsor, institution, collaborator, or mixed-role entity. These profiles are separated from the primary industry company index when appropriate.
Programs
2
linked to organization
Strong Evidence
0
0 status confirmed
Details Checked
2
0 open data checks
Company / Institution Links
0 / 2
industry vs non-industry records
Competitive Density
3
Pipeline Velocity
65
Completion Signal
100
Programs by Stage
Phase 42
Trial / Program Status
Active1
Completed1
Modality Mix
Small Molecule2
Indication Coverage
Tinnitus2
Program Types
Therapeutic2
Population Tags
adult2
tinnitus2
migraine1
migraine-associated1
repurposed-drug1
Strong-Evidence Records
0 recordsNo strong-evidence records are linked to this organization yet.
Checked Records With Caveats
2 checked · 0 open checksUC Irvine acute tinnitus migraine-medication study
Details checked
Small MoleculePhase 4Active
Active-not-recruiting randomized Phase 4 study comparing nortriptyline plus topiramate versus verapamil plus paroxetine for acute tinnitus, framed around migraine-associated tinnitus management.
Data checks: institution-led-study, active-not-recruiting
UC Irvine Migraine Medications Tinnitus Study
Details checked
Small MoleculePhase 4Completed
Academic randomized placebo-controlled Phase 4 trial evaluating two migraine-medication combination regimens for moderate to severe subjective tinnitus: nortriptyline plus topiramate and verapamil plus paroxetine. The combinations are trial arms using repurposed generic medications, not separate commercial pipeline programs.
Data checks: merged-generated-intervention-arms, institution-led-study